Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?D. Deniffel, E. Salinas, M. Ientilucci, A. J. Evans, N. Fleshner, S. Ghai, R. Hamilton, A. Roberts, A. Toi, T. van der Kwast, A. Zlotta, A. Finelli, M. A. Haider and N. Perlis J Urol 2020; doi: 10.1097/JU.0000000000001157. (2020)
Attributed to:
Defining the microenvironmental contexture of the biopsy-naive, MRI-characterized prostate.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/ju.0000000000001295
PubMed Identifier: 32698715
Publication URI: http://europepmc.org/abstract/MED/32698715
Type: Journal Article/Review
Volume: 204
Parent Publication: The Journal of urology
Issue: 5
ISSN: 0022-5347